Anaemia in the ICU: Is there an alternative to using blood transfusion?
|
|
- Mervyn Freeman
- 5 years ago
- Views:
Transcription
1 Anaemia in the ICU: Is there an alternative to using blood transfusion? Tim Walsh Professor of Critical Care, Edinburgh University
2 World Health Organisation grading of the severity of anaemia Grade of anaemia Haemoglobin range (g.dl -1 ) 0 (none) >11 1 (mild) (moderate) (severe) (life threatening) <6.5
3 No question! Not sure
4 Evolution of anaemia during intensive care ABC study (Europe) Vincent et al. JAMA 2002;288: CRIT study (US) Corwin et al. Crit Care Med 2004;32:39-52
5 Epidemiology of blood transfusion Study (reference) Study acronym Study size Case mix Mean (SD) population APACHE II score Transfusion trigger Proportion of admissions transfused (%) Vincent et al. JAMA ABC study 3534 Mixed multi-centre ICUs 14.8 (7.9) Mean 8.4 (SD 1.3) 37 Rao et al Anaesthesia None 1247 Mixed multi-centre general ICUs Transfused patients 19.0 (8.8) Non-transfused patients 16.3 (9.3) haemorrhage 8.5 (IQR: ) low haemoglobin 8.5 (IQR: ) 53 Corwin et al CCM CRIT study 4892 Mixed multi-centre ICUs 19.7 (8.2) Mean 8.6 (SD1.7) 44 Bellomo et al Med J Aus None 1808 Mixed general ICU Not given Mean 8.2 (range: ) 19.8 Walsh et al Transfusion; BJA; ICM ATICS study 1023 Mixed adult general ICUs (excluding cardiac) 19.8 (7.7) Median 7.8 (IQR: ) 39.5 Approximately 40% of ICU patients receive blood in the ICU, even with restrictive triggers About half is for non-haemorrhage transfusions
6 Anaemia at ICU admission Variable Estimate of value or prevalence Mean haemoglobin concentration at ICU admission 10.5 to 11.3 g.dl -1 Proportion of patients with Haemoglobin concentration <12 g.dl -1 Haemoglobin concentration <9 g.dl % 20-30% Prevalence of pre-existing anaemia at ICU admission 13%
7 766 ICU survivors in 10 Scottish ICUs Figure 2. Percentage of survivors who had haemoglobin <90 g/l during ICU stay with 95% CI % with Hb <90 g/l < 24 hours hours hours > 144 hours Length of ICU stay Walsh et al. Intensive Care Medicine 2006; 32:
8
9 Ann Intern Med. 2012;157(1): doi: /
10 Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis Lars B Holst et al. BMJ 2015; 350 doi:
11 Lecture plan Review the aetiology of anaemia during critical illness Consider the evidence for 3 nontransfusion interventions Minimisation of blood loss Iron therapy Erythropoietin therapy (with iron)
12 Lecture plan Review the aetiology of anaemia during critical illness Consider the evidence for 3 nontransfusion interventions Minimisation of blood loss Iron therapy Erythropoietin therapy (with iron)
13 Causes of anaemia during critical illness Pre-existing anaemia Acquired anaemia Haemodilution Blood loss Blood sampling Haemorrhage Reduced red cell survival Reduced red cell production Abnormal iron metabolism Nutritional deficiencies Inappropriate erythropoietin production Abnormal red cell production
14 Causes of anaemia during critical illness Pre-existing anaemia Acquired anaemia Haemodilution Blood loss Blood sampling Haemorrhage Reduced red cell survival Reduced red cell production Abnormal iron metabolism Nutritional deficiencies Inappropriate erythropoietin production Abnormal red cell production
15 What does haemoglobin concentration or HCT mean? 8 Haemorrhagic shock Healthy euvolaemic Post-operative resuscitated 6 4 PV 3L PV 5L 2 0 Blood volume (L) PV 1.7L RCV 1.3L HCT 0.4 RCV 2L HCT 0.4 RCV 2L HCT 0.28 Hb 13g/dL Hb 13g/dL Hb 9 g/dl
16 Causes of anaemia during critical illness Pre-existing anaemia Acquired anaemia Haemodilution Blood loss Blood sampling Haemorrhage Reduced red cell survival Reduced red cell production Abnormal iron metabolism Nutritional deficiencies Inappropriate erythropoietin production Abnormal red cell production
17 Erythroid indices during critical lllness Serum iron Total iron binding capacity Serum iron/total iron binding capacity ratio Ferritin Transferrin Transferrin saturation Vitamin B12 and folate Erythropoietin concentration Reticulocytes Serum transferrin receptors Change N N/slight increase Non-anaemic levels Normal
18 The anaemia of chronic disease Weiss, G. and Goodnough, L. T. N Engl J Med 2005;352:1011
19 The inflammatory hit The anaemia of chronic disease Weiss, G. and Goodnough, L. T. N Engl J Med 2005;352:1011
20 Effects of inflammation Inhibition of renal erythropoietin production Blunted inappropriate response to anaemia Direct effects on erythropoiesis in bone marrow Effects on acute phase proteins
21 Acute phase effects on the liver The anaemia of chronic disease Weiss, G. and Goodnough, L. T. N Engl J Med 2005;352:1011
22 Acute phase effects on the liver Up-regulation of ferritin production Increased storage iron Down-regulation of transferrin production Decreased iron availability for erythropoiesis Up-regulation of hepcidin production Decreased duodenal iron absorption
23 Altered iron handling by macrophages and RES The anaemia of chronic disease Weiss, G. and Goodnough, L. T. N Engl J Med 2005;352:1011
24 Effects on macrophage and RES Increased iron uptake Increased ferritin Opening of divalent metal transported protein Closure of ferroportin 1 Hepcidin mediated Increased phagocytosis of senescent red cells by activated macrophages Increased uptake of transferrin bound iron Functional iron deficiency
25 Impaired erythrogenesis The anaemia of chronic disease Weiss, G. and Goodnough, L. T. N Engl J Med 2005;352:1011
26 IF- inhibits and induces apoptosis TNF-, IL-1, and other cytokines may also inhibit maturation Pluripotential stem cells Erythroid burst forming unit Erythroid colony forming unit Pro-erythroblasts Erythroblasts Reticulocytes Erythrocytes Erythropoietin an essential growth factor Lack of reticulocyte response
27 Last Hb prior to ICU discharge among male and female ICU survivors (n = 766) Males Females Last Hb value in ICU 10.0 ( ) 9.8 ( ) Median (IQR) g/dl Last Hb in ICU < ref range [M <13; F <11.5 g/l] % Last Hb in ICU <9 g/dl % Walsh et al. Intensive Care Medicine 2006; 32:
28 Prevalence of different degrees of anaemia at hospital discharge. Hb level Males (n=161) N (%) Females (n=122) N (%) All patients (n=283) N (%) Hb < 90 g/l 14 (8.7) 18 (14.8) 32 (11.3) Hb < 100g/L 48 (29.8) 44 (36.1) 92 (32.5) Hb < reference range. 137 (85.1) 82 (67.2) 219 (77.4) Median days from ICU discharge to hospital discharge 13 (7.5, 24) days 50% of patients still in hospital after 3 weeks discharged with Hb < 10 g/dl 50% of all patients spending > 7 days in ICU discharged with Hb < 10 g/dl Walsh et al. Intensive Care Medicine 2006; 32: 1206
29 Characteristics of anaemia at hospital discharge Males n (%) Females n (%) n = 97 n = 65 Normochromic normocytic 76 (78) 56 (86) Normocytic hyperchromic 10 (10) 4 (6) Normo/microcytic hypochromic 5 (5) 3 (5) Other 6 (6) 2 (3) Walsh et al. Intensive Care Medicine 2006; 32: 1206
30 Hb g/l Hb g/l /30 29/30 21/22 16/20 19/22 12/19 10/ Weeks All Male Female At 13 weeks: 32% Hb <11 g/dl At 26 weeks: 16% Hb <11 g/dl Bateman et al. Critical Care Medicine; 37(6): , 2009
31 Factors associated with slow or failure to recover Higher circulating inflammatory markers following discharge (IL-6 and CRP) Lack of reticulocyte response Erythropoietin concentrations inappropriately low in all patients No evidence of nutritional deficiency Inflammatory anaemia
32 Summary With restrictive transfusion anaemia is highly prevalent in the ICU Anaemia is multifactorial, but inflammation is an important mechanism About 25% of patients are discharged with Hb <90 g/l Recovery is slow; anaemia is frequently moderate at hospital discharge In many patients anaemia persists for months The importance of anaemia to recovery after critical illness is unknown
33 Lecture plan Review the aetiology of anaemia during critical illness Consider the evidence for 3 nontransfusion interventions Minimisation of blood loss Iron therapy Erythropoietin therapy (with iron)
34 GRADE RECOMMENDATIONS 1: Summary of the Grade Recommendations Determination of the quality of evidence - Underlying methodology A. Randomised control trial B. A downgraded randomised control trial or high quality observational studies C. Well-done observational studies D. Case series or expert opinion - Factors that may decrease the strength of evidence 1. Poor quality of planning and implementation of available randomised control studies, increasing the risk of bias 2. Inconsistency of results 3. Indirectness of evidence 4. Imprecision of results 5. High likelihood of reporting bias - Main factors that may increase the strength of the evidence 1. Large magnitude of effect (direct evidence, relative risk >2, with no plausible confounders) 2. Very large magnitude of effect with RR >5 and no threats to validity 3. Dose respondent gradient Factors determining strong vs. weak recommendations Quality of evidence Relative importance of outcomes Baseline risk of outcomes Magnitude of relative risk Precision of the estimates of effect Cost The lower the quality of evidence the weaker the recommendation If values and results vary widely the weaker the recommendation The higher the risk, the greater the magnitude of effect The greater the benefit the stronger the recommendation The greater the precision the stronger the recommendation The greater the cost the weaker the recommendation
35 Lecture plan Review the aetiology of anaemia during critical illness Consider the evidence for 3 nontransfusion interventions Minimisation of blood loss Iron therapy Erythropoietin therapy (with iron)
36 Minimisation of blood loss Reducing phlebotomy frequency Reducing phlebotomy volumes Reinfusion devices for blood discards Low quality evidence Likely to decrease transfusion requirement and other costs Specific re-infusion devices available Needs system level change
37
38 Lecture plan Review the aetiology of anaemia during critical illness Consider the evidence for 3 nontransfusion interventions Minimisation of blood loss Iron therapy Erythropoietin therapy (with iron)
39 Iron therapy Most critically ill patients have a functional iron deficiency Oral iron unlikely to be absorbed and has risk of GI complications Few studies during critical illness Iron therapy does not increase reticulocyte counts No high quality studies showing benefit for important clinical outcomes, including blood transfusion Intravenous iron No high quality trials showing benefit during general critical illness No benefit in trauma critical care Crit Care Med 2014; 42: Concern in sepsis from risk of infection Association between IV iron and increased infection in non-critical care settings Systematic review BMJ 2013;347:f4822 doi: /bmj.f4822
40
41 Lecture plan Review the aetiology of anaemia during critical illness Consider the evidence for 3 nontransfusion interventions Minimisation of blood loss Iron therapy Erythropoietin therapy (with iron)
42 Erythropoietin therapy Corwin, H. L., et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial (EPO Critical Care Trials) JAMA, 288: MC DB RCT; n = 1302 weekly recombinant EPO (40,000IU) vs placebo 20% reduction in RBC transfusion in the treatment group Mean Hb transfusion trigger 90g/L Corwin, H. L, et al (2007) Efficacy and Safety of Epoetin Alfa in Critically Ill Patients NEJM, 357:10 pages MC DB RCT; n = 1460 medical, surgical and trauma patients (high proportion trauma patients) EPO vs placebo for 3 weeks no change in RBC transfusion mean haemoglobin transfusion trigger 80g/L higher Hb trend towards mortality advantage (more pronounced in trauma patients) significant increase in thrombotic events (especially among patients not receiving thromboprophylaxis)
43 Interpreting the erythropoietin literature Trial populations of interest; low risk of transfusion Balance of early therapy versus enrolment of patients with low transfusion requirements Transfusion practice; most did not use restrictive haemoglobin triggers close to 70g/L Uncertain benefit for long term patients at risk of chronic anaemia Variable dose and use of iron therapy Uncertain safety profile (especially thrombotic events) Uncertain cost-effectiveness
44
45 Summary Anaemia during critical illness is multifactorial Inflammation is a major mechanism resulting in functional iron deficiency and marrow suppression Minimising blood loss through sampling is simple and effective Based on current evidence routine use of oral or intravenous iron is not indicated Erythropoietin has unproven clinicaleffectiveness and safety and is not indicated
Transfusion for the sickest ICU patients: Are there unanswered questions?
Transfusion for the sickest ICU patients: Are there unanswered questions? Tim Walsh Professor of Critical Care Edinburgh University None Conflict of Interest Guidelines on the management of anaemia and
More informationRed Cell Transfusion triggers: A moving target When, who, and how much?
Red Cell Transfusion triggers: A moving target When, who, and how much? Tim Walsh Professor of Critical Care, Edinburgh University A transfusion threshold of 70 g/l or below, with a target Hb range of
More information27/01/2019. Anaemia, Transfusion and TACO Lise Estcourt. Anaemia. What is anaemia?
Anaemia, Transfusion and TACO Lise Estcourt 1 Anaemia 2 What is anaemia? 3 1 Anaemia according to WHO 4 Anaemia in palliative care Common (77% men 68% women) Symptoms often non-specific Some causes potentially
More informationUNIVERSA MEDICINA. Management of anemia among patients in intensive care units
UNIVERSA MEDICINA April-June 2008 Vol.27 - No.2 Management of anemia among patients in intensive care units Eveline Margo ABSTRACT Department of Physiology, Medical Faculty, Trisakti University Correspondence
More informationAnaemia & Cancer. John de Vos Consultant Haematologist RSCH
Anaemia & Cancer John de Vos Consultant Haematologist RSCH overview Definitions & setting the scene Causes Consequences Biology Treatment Personal approach Patient Clinical team Anaemia - Definition :
More informationIRON DEFICIENCY / ANAEMIA ANTHONY BEETON
IRON DEFICIENCY / ANAEMIA ANTHONY BEETON HYPOXIA 1-2 mg IRON Labile iron Body iron ± 3 4 g Liver and the reticuloendothelial system and spleen (approximately 200 300 mg in adult women and 1 g in adult
More informationErythropoiesis stimulationg agents: evidence for their use for the treatment of anemia in
Erythropoiesis stimulationg agents: evidence for their use for the treatment of anemia in thoracic tumors and MICU Dr Dipesh Maskey Senior Resident Dept of Pulmonary & CCM 14 th Oct 2011 Anemia and cancer
More informationManaging peri-operative anaemiathe Papworth way. Dr Andrew A Klein Royal Papworth Hospital Cambridge UK
Managing peri-operative anaemiathe Papworth way Dr Andrew A Klein Royal Papworth Hospital Cambridge UK Conflicts of interest: Unrestricted educational grants/honoraria from CSL Behring, Brightwake Ltd,
More informationClinical and Cost Effectiveness of Darbepoetin alfa in Cancer Treatment-induced Anaemia
Clinical and Cost Effectiveness of Darbepoetin alfa in Cancer Treatment-induced Anaemia 8 th November 2004 A report for the National Institute for Clinical Excellence prepared by Amgen Ltd. EXECUTIVE SUMMARY
More informationAssessing thrombocytopenia in the intensive care unit: The past, present, and future
Assessing thrombocytopenia in the intensive care unit: The past, present, and future Ryan Zarychanski MD MSc FRCPC Sections of Critical Care and of Hematology, University of Manitoba Disclosures FINANCIAL
More informationAlternatives to RBC Transfusion:
Alternatives to RBC Transfusion: beyond Erythropoietin and David Shimabukuro, MDCM Department of Anesthesia and Perioperative Care Medical Director, 13 ICU UC SF 1 Agenda Background Erythropoietin Hemoglobin-based
More informationManaging Anaemia in IBD
Oxford Inflammatory Bowel Disease & Hepatology MasterClass Managing Anaemia in IBD Dr Alex Kent Senior Research Fellow Disclosures WHO Classification of Anaemia Normal haemoglobin and haematocrit levels
More informationLaboratory diagnosis of iron deficiency: The interpretation of automated counting parameters. Dr Wayne Thomas Derriford Hospital, Plymouth
Laboratory diagnosis of iron deficiency: The interpretation of automated counting parameters. Dr Wayne Thomas Derriford Hospital, Plymouth Why does it matter? Over 30% of the Worlds population are anaemic,
More informationManagement of anemia in CKD
Management of anemia in CKD Pierre Cochat, MD PhD Professor of Pediatrics Chair, Pediatrics & Pediatric Surgery Department Head, Center for Rare Renal Diseases Néphrogones Hospices Civils de Lyon & University
More informationDr Marina Karakantza Consultant Haematologist, NHSBT
Dr Marina Karakantza Consultant Haematologist, NHSBT Overview Definition of transfusion thresholds Mechanisms of adaptation to anaemia How RBC transfusion affect adaptation mechanisms to anaemia Triggers
More informationObjectives. Current WHO Definition of Anemia. Implication for Clinical Practice 10/8/18. Prevalence of Iron Deficiency in Women Undergoing Surgery
Pre-operative Anemia Clinic Dr Mike Scott MB ChB FRCP FRCA FFICM Professor in Anesthesiology and Critical Care Medicine Divisional Lead for Critical Care Medicine VCU Health System, Richmond, VA Professor
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationDr Tushar Mahambrey. Consu ltant Critical Care Med icine & Anaesthetics St Helens and Knowsley N H S teaching hospitals Liverpool
Dr Tushar Mahambrey Consu ltant Critical Care Med icine & Anaesthetics St Helens and Knowsley N H S teaching hospitals Liverpool History Why do we give blood Why does anaemia occur in critical care patients
More informationRenal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Mikhail et al. BMC Nephrology (2017) 18:345 DOI 10.1186/s12882-017-0688-1 CORRESPONDENCE Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease Ashraf Mikhail 1*, Christopher
More informationAnemia Management: Using Epo and Iron
Anemia Management: Using Epo and Iron Ky Stoltzfus, MD University of Kansas Medical Center Assistant Professor Department of Internal Medicine January 23, 2013 Regulation of red cell production Treatment
More informationOverview of session. Blood transfusions in advanced disease 3/21/18. Why am I interested in blood transfusions?
Blood transfusions in advanced disease Dr Karen Neoh Registrar in Palliative Medicine, Leeds Teaching Hospital Trust and the Academic Unit of Palliative Care, University of Leeds Dr Jason Boland Senior
More informationYEAR III Pharm.D Dr. V. Chitra
YEAR III Pharm.D Dr. V. Chitra Anemia can be defined as a reduction in the hemoglobin,hematocrit or red cell number. In physiologic terms an anemia is any disorder in which the patient suffers from tissue
More informationBlood transfusions in sepsis, the elderly and patients with TBI
Blood transfusions in sepsis, the elderly and patients with TBI Shabbir Alekar MICU, CH Baragwanath Academic Hospital & The University of the Witwatersrand CCSSA Congress 11 June 2015 Packed RBC - complications
More informationEffective Health Care Program
Comparative Effectiveness Review Number 83 Effective Health Care Program Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease Executive Summary Background Chronic
More informationAlternatives to RBC Transfusion: Erythropoietin and beyond
Alternatives to RBC Transfusion: Erythropoietin and beyond David Shimabukuro, MDCM Department of Anesthesia and Perioperative Care Medical Director, 13 ICU UC SF 1 Agenda Physiology of Oxygen Transport
More informationEpogen / Procrit. Epogen / Procrit (epoetin alfa) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.06 Section: Prescription Drugs Effective Date: April1, 2014 Subject: Epogen / Procrit Page: 1 of 7
More informationThe Bleeding Jehovah s Witness: A Nightmare Scenario?
The Bleeding Jehovah s Witness: A Nightmare Scenario? David Smith, Bristol Hospital Liaison Committee for Jehovah s Witnesses SW RTC: Bleeding in the Medical Patient - 21 February 2018 Jehovah s Witnesses
More informationFaculty of Medicine Dr. Tariq Aladily
Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin
More informationNational Institute for Health and Care Excellence
National Institute for Health and Care Excellence 2-year surveillance (2017) Chronic kidney disease: managing anaemia (2015) NICE guideline NG8 Appendix A3: Summary of new evidence from surveillance Diagnostic
More informationERYTHROPOIETIC STIMULATING AGENTS IN THE ICU: A MOVING PUZZLE
ERYTHROPOIETIC STIMULATING AGENTS IN THE ICU: A MOVING PUZZLE WEIQIANG GAO HEM/ONC FELLOW FACULTY DISCUSSANT SIOBAN KEEL, MD OCT. 24, 2014 CASE PRESENTATION 25 F, a Jehovah s witness, w/ h/o synovial sarcoma
More informationRama Nada. -Ensherah Mokheemer. 1 P a g e
- 3 - Rama Nada -Ensherah Mokheemer - 1 P a g e Don t forget to refer to page index wherever you see * Quick revision: In the previous lecture we said that: - your body contains 4-5g of iron (4g in females
More informationANEMIA & HEMODIALYSIS
ANEMIA & HEMODIALYSIS The anemia of CKD is, in most patients, normocytic and normochromic, and is due primarily to reduced production of erythropoietin by the kidney and to shortened red cell survival.
More informationPrincipal Investigator. General Information. Certification. Research Proposal. Project Title
Principal Investigator First Name: Craig Last Name: French Degree: MD Primary Affiliation: Monash University E-mail: howard.l.corwin@gmail.com Phone number: 603 252-6829 Address: Department of Intensive
More informationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationNo Disclosures 03/20/2019. Learning Objectives. Renal Anemia: The Basics
Renal Anemia: The Basics Meredith Atkinson, M.D., M.H.S. Associate Professor of Pediatrics Johns Hopkins School of Medicine 16 March 2019 No Disclosures Learning Objectives At the end of this session the
More informationAnemia in the elderly. Nattiya Teawtrakul MD., PhD
Anemia in the elderly Nattiya Teawtrakul MD., PhD Contents Definition of anemia in the elderly The impact of anemia in the elderly Etiology of anemia in the elderly Management of anemia in the elderly
More informationPatient Blood Management and alternatives to transfusion
Patient Blood Management and alternatives to transfusion Patient Blood Management and the alternatives to transfusion and when these should be used Learning Outcomes Explain techniques that can be used
More informationChapter 2. ERYTHROPOIESIS and ANEMIA
Chapter 2 ERYTHROPOIESIS and ANEMIA Red Cell Production The Production of red cells, known as erythropoiesis, is a developmental system fundamentally under genetic control but modulated and regulated by
More informationDrugs Used in Anemia
Drugs Used in Anemia Drugs of Anemia Anemia is defined as a below-normal plasma hemoglobin concentration resulting from: a decreased number of circulating red blood cells or an abnormally low total hemoglobin
More informationPatient Blood Management: Enough is Enough
Patient Blood Management: Enough is Enough Richard Benjamin, MBChB, PhD, FRCPath Professor of Pathology Georgetown University Medical Center Washington, D.C. Chief Medical Officer Cerus Corporation Concord,
More informationScottish Medicines Consortium
Scottish Medicines Consortium epoetin theta, 1,000 IU/0.5mL, 2,000 IU/0.5mL, 3,000 IU/0.5mL, 4,000 IU/0.5mL, 5,000 IU/0.5mL, 10,000 IU/1mL, 20,000 IU/1mL, 30,000 IU/1mL solution for injection in pre filled
More informationControversies in Transfusion Medicine
Controversies in Transfusion Medicine Jeffrey L. Carson, M.D. Richard C. Reynolds Professor of Medicine Chief, Division of General Internal Medicine Robert Wood Johnson Medical School New Brunswick, New
More informationAnemia of Chronic Disease
J KMA Special Issue Anemia of Chronic Disease Chul Soo Kim, MD Department of Internal Medicine, Inha University College of Medicine Email : cskimmd@inha.ac.kr J Korean Med Assoc 2006; 49(10): 920-6 Abstract
More informationIron depletion in frequently donating whole blood donors. B. Mayer, H. Radtke
Iron depletion in frequently donating whole blood donors B. Mayer, H. Radtke Iron: relevance oxygen-transporting and storage proteins hemoglobin and myoglobin iron-containing centers in many enzymes mitochondrial
More informationBlood transfusions in ICU: double-edged sword. Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal
Blood transfusions in ICU: double-edged sword Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal Canadian Critical Care Trials Group Collaborating for Impact Leading
More informationA Guide To Safe Blood Transfusion Practice
A Guide To Safe Blood Transfusion Practice Marie Browett, Pavlina Sharp, Fiona Waller, Hafiz Qureshi, Malcolm Chambers (on behalf of the UHL Blood Transfusion Team) A Guide To Safe Blood Transfusion Practice
More informationDr Charlie Baker Consultant Anaesthetist UHNM. Being a place our f amilies would choose
Dr Charlie Baker Consultant Anaesthetist UHNM Being a place our f amilies would choose The story so far: Anaemia is associated with transfusion. The more anaemic you are pre op the more likely you are
More informationYear in Review: Critical Care Medicine
Year in Review: Critical Care Medicine No disclosures Eric J. Seeley, M.D. Assistant Professor of Medicine Division of Pulmonary and Critical Care Medicine Why I Selected These Studies High quality studies
More informationRENAL ANAEMIA. South West Renal Training Scheme Cardiff October 2018
RENAL ANAEMIA South West Renal Training Scheme Cardiff October 2018 Dr Soma Meran Clinical Senior Lecturer and Honorary Consultant Nephrologist, University Hospital of Wales. Aims Biology of renal anaemia
More informationBlood Conservation. To introduce the learner to the basic concepts of blood conservation!! Learning Outcomes
Section 4 Blood Conservation Aim To introduce the learner to the basic concepts of blood conservation Learning Outcomes Identify the principles of blood conservation Identify the areas where blood conservation
More informationINTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED
INTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED Rationale for Combining Iron & Vit-D Vit D deficiency and Iron deficiency Anaemia the two most menacing disorders - are inter-related
More informationHaematology and Transfusion
Haematology and Transfusion Prof Dr Wolfram Engelhardt Anaesthesiology and Intensive Care Medicine Offenburg Hospital, Germany dr.w.engelhardt@gmail.com James Blundell 1828 Lancet 1828; 11:321 Erythrocytes
More informationAn Audit of Poor Response To Erythropoeitin Therapy. September 1998
1 An Audit of Poor Response To Erythropoeitin Therapy September 1998 Prepared By: Nicola Austerberry Renal Audit Facilitator Phil Kalra Consultant Nephrologist 2 1 Introduction The topic for this audit
More informationMartin Besser Consultant Haematologist Papworth Hospital
Martin Besser Consultant Haematologist Papworth Hospital Important modifiable risk factor for morbidity and mortality in all forms of surgery (Australian PBM guidelines) 140g/l 100g/l 80g/l Patients should
More informationBONE MARROW PERIPHERAL BLOOD Erythrocyte
None Disclaimer Objectives Define anemia Classify anemia according to pathogenesis & clinical significance Understand Red cell indices Relate the red cell indices with type of anemia Interpret CBC to approach
More informationAnemia Management in Peritoneal Dialysis Patients Pranay Kathuria, FACP, FASN
Anemia Management in Peritoneal Dialysis Patients Pranay Kathuria, FACP, FASN Professor of Medicine Director, Division of Nephrology and Hypertension University of Oklahoma College of Medicine Definition
More informationAn Oncologist s Approach to Anemia in Adults Christie J. Hilton, DO
An Oncologists Approach to Anemia in Adults (There are not many updates) Christie Hilton DO POMA Winter Symposium 2019 Nemicolin Woodlands 8 Disclosures None 9 Objectives Define anemia Review the classification
More informationEpoetin 2000 I.U. SEDICO & 4000 I.U. SEDICO & Anemia of Chronic Renal Failure & In Cancer Patients. Anemia of Chronic Renal Failure
SEDICO Newsletter Vol.11 Epoetin 2000 I.U. SEDICO & 4000 I.U. SEDICO & Anemia of Chronic Renal Failure & In Cancer Patients Anemia of Chronic Renal Failure The association of chronic renal failure and
More informationferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals
ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals 17 December 2010 The Scottish Medicines Consortium (SMC) has completed its assessment
More informationManaging Delirium: The best way to achieve clarity (of mind) Tim Walsh. Professor of Critical Care, Edinburgh University
Managing Delirium: The best way to achieve clarity (of mind) Tim Walsh Professor of Critical Care, Edinburgh University Lecture Plan: a route to clarity What is delirium? Why is delirium important? Step
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More informationDefinition Aetiology
Definition Anaemia is a fall in haemoglobin below the reference ranges for age and sex (adult female
More informationTransfusion Triggers. Richard Soutar January 2012
Transfusion Triggers Richard Soutar January 2012 1 Educational objectives: To understand the risks of transfusion - the known, the uncertain and unknown To understand the fear of the unknown in Transfusion
More informationAnemia Update. Target Hb TREAT study Functional iron deficiency - Hepcidin Biosimilar epoetins
Anemia Update Peter Bárány Department of Renal Medicine/ Karolinska University Hospital and Division of Renal Medicine Department of Clinical Science, Intervention and Technology Karolinska Institutet,
More informationClinical practice guideline: Red blood cell transfusion in adult trauma and critical care*
Special Article Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care* Lena M. Napolitano, MD; Stanley Kurek, DO; Fred A. Luchette, MD; Howard L. Corwin, MD; Philip
More informationTransfusion. National Clinical Guideline Centre. Blood transfusion. Clinical guideline. November Final version.
National Clinical Guideline Centre 1 Final version Transfusion Blood transfusion Clinical guideline Appendices H-I November 2015 Final version Commissioned by the National Institute for Health and Care
More informationferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd
Resubmission ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd 06 May 2011 The Scottish Medicines Consortium (SMC) has completed its assessment
More informationPeer Review Report. [erythropoietin-stimulating agents]
21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report [erythropoietin-stimulating agents] (1) Does the application adequately address the issue of the public health need
More informationBritish Society of Gastroenterology. St. Elsewhere's Hospital. National Comparative Audit of Blood Transfusion
British Society of Gastroenterology UK Com parat ive Audit of Upper Gast roint est inal Bleeding and t he Use of Blood Transfusion Extract December 2007 St. Elsewhere's Hospital National Comparative Audit
More informationHemoglobin. Each alpha subunit has 141 amino acids, and each beta subunit has 146 amino acids.
In the previous lecture we talked about erythropoiesis and its regulation by many vitamins like vitamin B12 and folic acid, proteins, iron and trace elements copper and cobalt. Also we talked about pernicious
More informationIron metabolism and medical needs: a view from Academia
Iron metabolism and medical needs: a view from Academia Paul M. Tulkens Cellular & Molecular Pharmacology & Centre for Clinical Pharmacy Catholic University of Louvain Brussels, Belgium Iron therapy Master
More informationEfficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia. Ioannis Griveas, MD, PhD
Efficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia Ioannis Griveas, MD, PhD Anaemia is a state in which the quality and/or quantity of circulating red blood cells are below
More informationLiterature Scan: Erythropoiesis Stimulating Agents
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationPreoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD
Preoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD Preoperative anemia is common, especially in patients undergoing nonemergent high-blood-loss surgical
More informationMicrocytic Hypochromic Anemia An Approach to Diagnosis
Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation
More informationThe Use of Metabolic Resuscitation in Sepsis
The Use of Metabolic Resuscitation in Sepsis Jennifer M. Roth, PharmD, BCPS, BCCCP Critical Care Clinical Specialist - Surgical Trauma ICU Baylor University Medical Center Disclosures No conflicts of interest
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Epoetin alfa HEXAL 1,000 IU/0.5 ml solution for injection in a pre-filled syringe Epoetin alfa HEXAL 2,000 IU/1 ml solution
More informationIntroduction and II. Blood Cells A. Introduction
Chapter 14: Blood 1. Blood is three to four times more viscous than water. Introduction and II. Blood Cells A. Introduction 2. Most blood cells form in red bone marrow. 3. Types of blood cells are red
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Retacrit 1 000 IU/0.3 ml solution for injection in pre-filled syringe Retacrit 2 000 IU/0.6 ml solution for injection in pre-filled
More informationIron metabolism anemia and beyond. Jacek Lange Perm, 8 October 2016
Iron metabolism anemia and beyond Jacek Lange Perm, 8 October 2016 1 Overview 1. Iron metabolism 2. CKD Chronic Kidney Disease 3. Iron deficiency beyond anemia and CKD 4. Conclusions 2 Why iron deficiency
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationRed cell disorder. Dr. Ahmed Hasan
Red cell disorder Dr. Ahmed Hasan Things to be learned in this lecture Definition and clinical feature of anemia. Classification of anemia. Know some details of microcytic anemia Question of the lecture:
More informationClassification of Anaemia
Classification of Anaemia Dr Roger Pool Department of Haematology NHLS & University of Pretoria MEASUREMENT OF HAEMATOCRIT The haematocrit ratio (Hct) is the proportion of blood made up of cells - mainly
More informationA Systemic Review of Iron Deficiency Anemia in Adults and the Clinical Management of Diagnosis and Treatment
A Systemic Review of Iron Deficiency Anemia in Adults and the Clinical Management of Diagnosis and Treatment Dr. Mohammed Owaid O. Alshammari Dr. Mahdee Hemaidan M Albeqami Dr. Alhashim, Jehad Nizar A
More informationNutritional anaemia. Dr J Potgieter Dept of Haematology NHLS - TAD
Nutritional anaemia Dr J Potgieter Dept of Haematology NHLS - TAD Classification of anaemia Microcytic, hypochromic MCV < 80fl MCH > 27pg Iron deficiency Anaemia of chronic disease Thalassaemia Lead poisoning
More informationEVIDENCE BASED RED CELL TRANSFUSION. Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System
EVIDENCE BASED RED CELL TRANSFUSION Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System HISTORY Blood transfusion works (ie: red cell transfusion saves lives). based on
More informationAnemia 1: Fourth year Medical Students/ Feb/22/ Abdallah Awidi Abbadi.MD.FRCP.FRCPath Professor
Anemia 1: Fourth year Medical Students/ Feb/22/ 2018 Abdallah Awidi Abbadi.MD.FRCP.FRCPath Professor Email: abdalla.awidi@gmail.com Kidney EPO O2 Sensor Blood vessel Definition: Anemia is operationally
More informationCentocor Ortho Biotech Services, LLC
SYNOPSIS Issue Date: 17 June 2009 Name of Sponsor/Company Name of Finished Product PROCRIT Name of Active Ingredient(s) Protocol No.: PR04-15-001 Centocor Ortho Biotech Services, LLC Epoetin alfa Title
More informationHistory. n 1865 First description of reticulocytes by Erb, who. n 1881 Using supravital staining, Ehrlich demonstrated
SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT JANUARY 2016 SEED HAEMATOLOGY The importance of reticulocyte detection Production of reticulocytes All blood cells emanate from a stem cell. Under pronounced
More informationBlood doping: is it effective? Brien AJ, Simon TL. Effects of red blood cell infusion on 10-km race time. JAMA 1987
Blood doping the attempt to increase the total amount of circulating hemoglobin (and oxygen transport to tisses) through illegal practices used since 70s in endurance sports diffused during 90s to now
More informationBlood and blood component therapy in the critically ill patient
Blood and blood component therapy in the critically ill patient Dr Liesel Bösenberg Specialist Physician and Fellow in Critical Care Kalafong Hospital Points that we shall ponder Transfusion triggers EGDT
More informationCELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK: CISS Phase I Trial
CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK: CISS Phase I Trial Lauralyn McIntyre, MD, FRCPC, MHSc Associate Professor, University of Ottawa Senior Scientist, Ottawa Hospital Research Institute CCCF MEETING,
More informationThe Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital
The Ever Changing World of Sepsis Management Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital COI Disclosures No financial interests to disclose Learning Objectives Review the evolution
More informationTypes of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014
Types of Anaemias and their Management S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Objectives At the end of the presentations participants should be able to: 1. Define
More informationScottish Medicines Consortium
Scottish Medicines Consortium epoetin zeta, 1000 IU/0.3ml, 2000 IU/0.6ml, 3000 IU/0.9ml, 4000 IU/0.4ml, 5000 IU/0.5ml, 6000 IU/0.6ml, 8000 IU/0.8ml, 10,000 IU/1.0ml, 20,000 IU/0.5ml, 30,000 IU/0.75ml and
More informationRole of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure
ORIGINAL ARTICLE JIACM 2009; 10(1 & 2): 18-22 Abstract Role of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure N Nand*, HK Aggarwal**,
More informationTransfusions in Acute Care Too Little?
Transfusions in Acute Care Too Little? Keyvan Karkouti MD FRCPC MSc Associate Professor Department of Anesthesia; Department of Health Policy, Management, and Evaluation; University of Toronto Scientist
More informationMorris A. Blajchman, MD, FRCP(C) Emeritus Professor, McMaster University Hamilton, Ontario, CANADA
Morris A. Blajchman, MD, FRCP(C) Emeritus Professor, McMaster University Hamilton, Ontario, CANADA RBC TRANSFUSIONS: GENERAL PRINCIPLES RBCs are usually dispensed on a first-in, first-out basis. Storage
More informationAntioxidant Dosing and Micronutrient Management in the Intensive Care Unit
PENSA 2017 November 21, 2017 Antioxidant Dosing and Micronutrient Management in the Intensive Care Unit Lingtak-Neander Chan, PharmD, BCNSP, CNSC, FACN Professor of Pharmacy, Interdisciplinary Faculty
More information